Back to top
more

Zimmer Biomet Holdings, Inc. (ZBH)

(Real Time Quote from BATS)

$159.24 USD

159.24
897,510

-1.15 (-0.72%)

Updated Jun 18, 2021 03:23 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 21% (199 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for ZBH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Zimmer Biomet Holdings, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 802 618 543 524 634
Receivables 1,453 1,364 1,276 1,495 1,604
Notes Receivable 0 0 0 0 0
Inventories 2,451 2,385 2,257 2,082 1,959
Other Current Assets 378 357 352 415 466
Total Current Assets 5,083 4,724 4,427 4,515 4,664
Net Property & Equipment 2,048 2,077 2,015 2,039 2,038
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 16,317 16,857 17,279 19,022 19,429
Deposits & Other Assets 969 980 405 389 554
Total Assets 24,418 24,639 24,127 25,965 26,684
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 330 401 363 330 365
Current Portion Long-Term Debt 500 1,500 525 1,225 576
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 60 127 142 165 184
Other Current Liabilities 1,667 1,414 1,391 1,300 1,258
Total Current Liabilities 2,557 3,442 2,421 3,020 2,382
Mortgages 0 0 0 0 0
Deferred Taxes/Income 790 840 1,000 1,102 3,031
Convertible Debt 0 0 0 0 0
Long-Term Debt 7,627 6,721 8,414 8,918 10,666
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,245 1,243 1,016 1,190 936
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 12,218 12,246 12,851 14,229 17,015
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 9,122 8,920 8,686 8,515 8,369
Retained Earnings 10,087 10,427 9,491 10,023 8,467
Other Equity -293 -237 -183 -84 -433
Treasury Stock 6,720 6,721 6,722 6,722 6,736
Total Shareholder's Equity 12,199 12,393 11,276 11,736 9,670
Total Liabilities & Shareholder's Equity 24,418 24,639 24,127 25,965 26,684
Total Common Equity 12,199 12,393 11,276 11,736 9,670
Shares Outstanding 207.20 205.60 203.90 202.40 200.30
Book Value Per Share 58.88 60.28 55.30 57.98 48.28

Fiscal Year End for Zimmer Biomet Holdings, Inc. falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents 724 802 967 713 2,434
Receivables 1,380 1,453 1,341 1,065 1,039
Notes Receivable 0 0 0 0 0
Inventories 2,512 2,451 2,492 2,497 2,463
Other Current Assets 384 378 352 432 435
Total Current Assets 5,000 5,083 5,153 4,707 6,371
Net Property & Equipment 2,022 2,048 2,043 2,057 2,066
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 16,034 16,317 15,889 15,920 16,029
Deposits & Other Assets 970 969 941 965 1,048
Total Assets 24,027 24,418 24,026 23,648 25,513
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 330 330 335 363 405
Current Portion Long-Term Debt 300 500 450 450 1,950
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 235 0 0 215 182
Income Taxes Payable 36 60 121 122 93
Other Current Liabilities 1,188 1,667 1,361 1,011 1,150
Total Current Liabilities 2,089 2,557 2,266 2,161 3,780
Mortgages 0 0 0 0 0
Deferred Taxes/Income 766 790 748 805 858
Convertible Debt 0 0 0 0 0
Long-Term Debt 7,539 7,627 7,840 7,759 7,724
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,183 1,293 1,278 1,269
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 11,577 12,218 12,147 12,004 13,630
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 9,199 9,122 9,073 9,014 8,984
Retained Earnings 10,238 10,087 9,803 9,610 9,866
Other Equity -272 -293 -281 -263 -251
Treasury Stock 6,718 6,720 6,720 6,720 6,720
Total Shareholder's Equity 12,450 12,199 11,878 11,644 11,883
Total Liabilities & Shareholder's Equity 24,027 24,418 24,026 23,648 25,513
Total Common Equity 12,450 12,199 11,878 11,644 11,883
Shares Outstanding 208.40 207.20 207.20 207.00 206.40
Book Value Per Share 59.74 58.88 57.33 56.25 57.57